Platform
All Zus products are built on top of a HIPAA-compliant FHIR-native data store, which includes detailed provenance and a terminology service.
zushealth.comCrawled Oct 15, 2026
All Zus products are built on top of a HIPAA-compliant FHIR-native data store, which includes detailed provenance and a terminology service.
The company is building customizable features that users can select to meet technology-stack-specific needs.
Details like demographics, coverage, care team, and medications matter. Leveraging the Zus Patient History API, Zus patient profiles include all the key information – and are flexibly available through either an API or embedded UI element.
These are pretty commonplace decisions where most developers have a preference based on their previous experiences. Things get interesting when the line between buy and build becomes blurred, particularly for cross cutting functionality like authentication.
The page describes an emerging healthcare data landscape and conflicting business motives.
The first installment of the Zus Q&A series features Dave Boerner discussing the current landscape of interoperability.
The company says its work is guided by compassion for patients and its people, and that diverse backgrounds strengthen collaboration on new solutions.
In a conversation with Zus Health CEO Jonathan Bush, Larry from Tennessee Oncology discusses a familiar challenge in oncology care: patient data exists, but turning it into something clinicians can actually use takes too long.
The page says digital health is more usable for many patients and care providers, while outdated tools and limited systems put digitally enabled care at risk.
Zus Health 1 Lincoln St., Suite 2900 Boston, MA 02111
Zus provides patient data at the point of care through an API, embedded components, and direct EHR integrations to support healthcare data interoperability. Its mission is to maximize patient insights for value-based care.
The definition covers activities of a Covered Entity related to covered functions, including quality assessment and improvement, clinical guideline development, patient safety, and population-based activities.
Zus Health secures **$33 million in Series B funding**, led by Drive Capital. The Boston-based company develops a technology platform for connected healthcare solutions, integrating devices and data to improve patient care.
Zus Health secures **$33 million in Series B funding** to expand its healthcare technology platform. The company focuses on improving connectivity and integration across healthcare systems. This latest round supports further development of its tools for providers and patients.
Zus Health raises **$33M in Series B funding** to develop a **national healthcare data network** and **AI-driven clinical workflows**, led by Drive Capital with participation from Sanofi Ventures, HealthX Ventures, and Andreessen Horowitz. The company’s **FHIR-native patient record platform** aggregates fragmented EHR data into a unified, longitudinal profile, enabling seamless interoperability and AI-powered automation for care teams. Zus’s **Zus Aggregated Profile (ZAP)** integrates pharmacy, lab, and care event data, supporting over **110M monthly transactions** and **39M AI-generated evidence citations** year-to-date. The funding will accelerate AI-native clinical intelligence for use cases like **risk adjustment, transitions of care, and population health management** while expanding its network of providers and digital health partners.
Zus Health secures **$33 million** in a Series B funding round led by **Drive Capital**, pushing its total raised to over **$100 million**. The AI-driven healthcare data platform leverages machine learning to aggregate and analyze patient records for clinical decision support. Drive Capital’s involvement signals growing investor confidence in Zus’s ability to streamline healthcare data integration.
Zus Health secures **$33 million in Series B funding** to advance its connected healthcare platform. The round is led by **Drive Capital**, with support from **Sanofi Ventures, HealthX Ventures, and Alumni Ventures**, alongside returning backers including **Andreessen Horowitz, F-Prime, Maverick Ventures, and JAZZ Venture Partners**. The funding will drive development of next-generation healthcare technology solutions.
Zus Health secures **$33 million in Series B funding** to expand its AI-driven health data platform, addressing fragmented legacy electronic health record (EHR) systems. The company, founded in 2021 by **Jonathan Bush** (co-founder of athenahealth), builds infrastructure to streamline data integration for digital health developers and providers. Its platform aims to replace custom-built data pipelines with standardized, AI-optimized solutions.